UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Human pathology, 2015-03, Vol.46 (3), p.357-365

2015

Volltextzugriff (PDF)

Treatment of uveal melanoma: where are we now?

Therapeutic Advances in Medical Oncology, 2018-01, Vol.10, p.1758834018757175-1758834018757175

2018

Volltextzugriff (PDF)

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma

Cancers, 2019-07, Vol.11 (7), p.971

2019

Volltextzugriff (PDF)

Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

Science translational medicine, 2014-10, Vol.6 (260), p.260ra149

2014

Volltextzugriff (PDF)

KIT as a therapeutic target in metastatic melanoma

JAMA : the journal of the American Medical Association, 2011-06, Vol.305 (22), p.2327

2011

Volltextzugriff (PDF)

Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

Current oncology reports, 2017-07, Vol.19 (7), p.45-45, Article 45

2017

Volltextzugriff (PDF)

Editorial: Non-cutaneous melanoma: new therapeutic insights

Frontiers in oncology, 2024-01, Vol.13, p.1362238-1362238

2024

Volltextzugriff (PDF)

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

The oncologist (Dayton, Ohio), 2016-07, Vol.21 (7), p.848-854

2016

Volltextzugriff (PDF)

Aurora Kinases: New Targets for Cancer Therapy

Clinical cancer research, 2006-12, Vol.12 (23), p.6869-6875

2006

Volltextzugriff (PDF)

Another option in our KIT of effective therapies for advanced melanoma

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3173-3175

Carvajal, Richard D

2013

Volltextzugriff (PDF)

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature genetics, 2023-01, Vol.55 (1), p.19-25

2023

Volltextzugriff (PDF)

Prognosis of Acral Melanoma: A Series of 281 Patients

Annals of surgical oncology, 2013-10, Vol.20 (11), p.3618-3625

2013

Volltextzugriff (PDF)

Arginine depletion as a therapeutic approach for patients with COVID-19

International journal of infectious diseases, 2021-01, Vol.102, p.566-570

2021

Volltextzugriff (PDF)

Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition

Journal of clinical oncology, 2012-07, Vol.30 (19), p.2375-2383

2012

Volltextzugriff (PDF)

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF -Mutant Melanoma

Cancers, 2019-10, Vol.11 (11), p.1642

2019

Volltextzugriff (PDF)

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

Molecular cancer therapeutics, 2020-04, Vol.19 (4), p.1031-1039

2020

Volltextzugriff (PDF)

MicroRNA‐based risk scoring system to identify early‐stage oral squamous cell carcinoma patients at high‐risk for cancer‐specific mortality

Head & neck, 2020-08, Vol.42 (8), p.1699-1712

2020

Volltextzugriff (PDF)

Advances in Prevention and Surveillance of Cutaneous Malignancies

The American journal of medicine, 2020-04, Vol.133 (4), p.417-423

2020

Volltextzugriff (PDF)

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition

Clinical cancer research, 2015-05, Vol.21 (10), p.2289-2296

2015

Volltextzugriff (PDF)

Treatment implications of the emerging molecular classification system for melanoma

The lancet oncology, 2011-09, Vol.12 (9), p.913-922

2011

Volltextzugriff (PDF)

A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma

Frontiers in oncology, 2023-06, Vol.12, p.975642-975642

2023

Volltextzugriff (PDF)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

EMBO molecular medicine, 2019-02, Vol.11 (2), p.n/a

2019

Volltextzugriff (PDF)

Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance

Clinical cancer research, 2012-07, Vol.18 (13), p.3552-3561

2012

Volltextzugriff (PDF)

The reporting of uveal melanoma cases to the cancer registry in North Carolina

Frontiers in oncology, 2022-08, Vol.12, p.877599-877599

2022

Volltextzugriff (PDF)

Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma

Clinical cancer research, 2011-04, Vol.17 (8), p.2087-2100

2011

Volltextzugriff (PDF)

1 – 25 von 378

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(321)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Treatment of uveal melanoma: where are we now?

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma

Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

KIT as a therapeutic target in metastatic melanoma

Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

Editorial: Non-cutaneous melanoma: new therapeutic insights

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

Aurora Kinases: New Targets for Cancer Therapy

Another option in our KIT of effective therapies for advanced melanoma

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Prognosis of Acral Melanoma: A Series of 281 Patients

Arginine depletion as a therapeutic approach for patients with COVID-19

Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF -Mutant Melanoma

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

MicroRNA‐based risk scoring system to identify early‐stage oral squamous cell carcinoma patients at high‐risk for cancer‐specific mortality

Advances in Prevention and Surveillance of Cutaneous Malignancies

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition

Treatment implications of the emerging molecular classification system for melanoma

A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance

The reporting of uveal melanoma cases to the cancer registry in North Carolina

Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma

Suchergebnisse filtern